Back to Journals » Cancer Management and Research
Cancer Management and Research
ISSN: 1179-1322
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4616)
- Volume 16, 2024 (22)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Efficacy and Safety of Maintenance Therapy Using Cetuximab in Patients with Metastatic Colorectal Cancer: Retrospective Study
Xuan T, Wang Z, Meng S, Li J, Li J, Cao F, Qu L
Cancer Management and Research 2024, 16:185-197
Published Date: 19 March 2024
Extensive Stage Small-Cell Lung Cancer with Cystic Brain Metastases: A Report of Two Cases
Cai F, Wu D, Liu J, Song S, Li J, Zheng Z, Xu L
Cancer Management and Research 2024, 16:177-183
Published Date: 18 March 2024
Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study
Xue T, Yu H, Feng W, Wang Y, Wu S, Wang L, Zhu P, Guan J, Sun Q
Cancer Management and Research 2024, 16:163-175
Published Date: 14 March 2024
Immune-Related Adverse Event-Related Adrenal Insufficiency Mediates Immune Checkpoint Inhibitors Efficacy in Cancer Treatment
Zhang S, Wu J, Zhao Y, Zhang J, Zhang X, Wu C, Zhang Z, Guo Z
Cancer Management and Research 2024, 16:151-161
Published Date: 14 March 2024
SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer
Ning L, Xie N
Cancer Management and Research 2024, 16:137-150
Published Date: 8 March 2024